Industry

Oncodesign is Granted New Patent Protecting Key Molecules Generated from Its Nanocyclix Technology Platform for Next Generation Kinase Inhibitors

Oncodesign  (Paris:ALONC) (ALONC – FR0011766229), a biotechnology company serving the pharmaceutical industry in the discovery of new therapeutic molecules to fight